Exploration of the Biologic Basis for Underperformance of Oral Polio and Rotavirus Vaccines in Bangladesh

Last updated: April 25, 2025
Sponsor: University of Vermont
Overall Status: Completed

Phase

3

Condition

Lactose Intolerance

Stomach Discomfort

Colic

Treatment

IPV (inactivated polio vaccine)

Rotarix

Clinical Study ID

NCT01375647
PROVIDE
  • Ages < 7
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

Oral polio and rotavirus vaccines are significantly less effective in children living in the developing world. Tropical enteropathy, which is associated with intestinal inflammation, decreased absorption and increased permeability, may contribute substantially to oral vaccine failure in developing country settings. Other possible causes of oral vaccine underperformance include malnutrition, interference with maternal or breastmilk antibodies, changes in gut microbiota, and genetic susceptibility.

Primary Objective: to determine whether tropical enteropathy impairs the efficacy of oral polio and rotavirus vaccines in children in Bangladesh.

Secondary Objectives: 1) to determine the impact of an IPV (inactivated polio vaccine) boost on the efficacy of OPV (oral polio vaccine) and 2) to determine the efficacy of Rotarix oral rotavirus vaccine to prevent rotavirus diarrhea

The polio and rotavirus randomized clinical trials are embedded as secondary objectives within the exploratory study of tropical enteropathy. The primary and secondary outcome measures are relevant to the randomized clinical trials.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Mother willing to sign informed consent form.

  2. Healthy infant aged 0 to 7 days old.

  3. No obvious congenital abnormalities or birth defects.

  4. No abnormal (frequency and consistency) stools since birth.

  5. Stable household with no plans to leave the area for the next one year.

Exclusion

Exclusion Criteria:

  1. Parents are not willing to have child vaccinated at the field clinic.

  2. Parents are not willing to have child's blood drawn.

  3. Parents are planning to enroll child into another clinical study during the timeperiod of this trial.

  4. Mother not willing to have blood drawn and breast milk extracted.

  5. Parents not willing to have field research assistant in home two times per week.

  6. History of seizures or other apparent neurologic disorders.

  7. Infant received any vaccines before start of study, except Bacillus Calmette-Guerin (BCG).

  8. Infant has any sibling currently or previously enrolled in this study, including atwin.

Study Design

Total Participants: 700
Treatment Group(s): 2
Primary Treatment: IPV (inactivated polio vaccine)
Phase: 3
Study Start date:
May 01, 2011
Estimated Completion Date:
November 30, 2014

Connect with a study center

  • International Centre for Diarrhoeal Disease Research, Bangladesh

    Dhaka,
    Bangladesh

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.